Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

Abstract Background The novel coronavirus pandemic calls for a rapid adaptation of conventional medical practices to meet the evolving needs of such vulnerable patients. People with coronavirus disease (COVID-19) may frequently require treatment with psychotropic medications, but are at the same tim...

Full description

Bibliographic Details
Main Authors: Giovanni Ostuzzi, Davide Papola, Chiara Gastaldon, Georgios Schoretsanitis, Federico Bertolini, Francesco Amaddeo, Alessandro Cuomo, Robin Emsley, Andrea Fagiolini, Giuseppe Imperadore, Taishiro Kishimoto, Giulia Michencigh, Michela Nosé, Marianna Purgato, Dursun Serdar, Brendon Stubbs, David Taylor, Graham Thornicroft, Philip B. Ward, Christoph Hiemke, Christoph U. Correll, Corrado Barbui
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Medicine
Subjects:
Novel coronavirus
COVID-19
Psychopharmacology
Psychiatric comorbidity
Drug–drug interactions
Online Access:http://link.springer.com/article/10.1186/s12916-020-01685-9

Internet

http://link.springer.com/article/10.1186/s12916-020-01685-9

Similar Items